| 1/5 | US=2 / Farmacologia Prante O, Dörfler M, Gmeiner P. Dopamine receptor subtype-selective drugus: D2-like receptors. In: Neve KA. The dopamine receptors. 2ªed. New York: Humana Press, 2009. p. 101-35. ISBN 978-1-60327-332-9. D1 COMO RECEPTORES; SELETIVIDADE SOBE SUBTIPO; AMINOTETRALINS; PHENYLPIPERAZINE; RADIOLIGANTE; D3 RECEPTORES; D4 RECEPTORES |
| 2/5 | US=89 / Biol/Mol Schirrmacher V, Fournier P. Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 565-605. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. VIRUS DA DOENCA DE NEWCASTLE; TERAPIA VIRAL; TERAPIA IMUNE; TERAPIA GENICA DO CANCRO; MODULACAO IMUNE; SELETIVIDADE DO TUMOR; VACINA CONTRA TUMOR |
| 3/5 | US=56 / Biol/Mol Niles AL, Moravec RA, Riss TL. Caspase activity assays. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 137-50. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. CASPASE; ENSAIOS DE ATIVIDADE; SELETIVIDADE; CELULA BASEADA; INDUCAO; INIBICAO; FLUORESCENCIA; LUMINESCENCIA |
| 4/5 | US=58 / Câncer Pevarello P, Bischoff JR, Mercurio C. Targeting cyclin-dependent kinases with small molecular inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 235-44. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CICLINA DEPENDENTE DE QUINASE; INIBIDOR DE MOLECULA PEQUENA; SELETIVIDADE; DE MULTI-ALVO; ENSAIOS CLINICOS |
| 5/5 | US=95 / Biol/Mol Yamamoto M, Curiel DT. Gene therapy approaches: tumor targeting-retargeted adenovirus. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 197-212. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; TUMOR ADENOVIRUS-ALVO REDIRECIONADA; SELETIVIDADE; INFECTIVIDADE; INFECCAO ADENOVIRAL |